The prevalence of soft tissue sarcoma has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence of soft tissue sarcoma and the
Asthma is a chronic disease that affects a substantial number of patients worldwide, including children, a number of pharmaceutical companies are involved in developing drugs for asthma. This
Growing Research in Novel Biologics and Rising Government Reimbursement on Drug Pricing will Propel the Overall Market for Rheumatoid Arthritis Treatment